Palivizumab and RSV prevention

被引：0

|

作者：

Carnegie, C ^{[1
]}

机构：

[1] Abbott Labs Ltd, Queenborough, England

来源：

ARCHIVES OF DISEASE IN CHILDHOOD | 2000年 / 83卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

引用

收藏

页码：87 / 88

页数：2

相关论文

共 50 条

[1] Palivizumab and RSV prevention - Comment
Marcovitch, H
ARCHIVES OF DISEASE IN CHILDHOOD, 2000, 83 (01) : 88 - 88
[2] Cost minimisation of RSV prevention with palivizumab
Wills, S.
Simpson, J. H.
Coutts, J.
ARCHIVES OF DISEASE IN CHILDHOOD, 2006, 91 (08) : 717 - 717
[3] Palivizumab (Synagis) for prevention of RSV infection
不详
MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 1999, 41 (1043): : 3 - 4
[4] Respiratory syncytial virus (RSV) immune globulin and palivizumab for prevention of RSV infection
Robinson, RF
Nahata, MC
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2000, 57 (03) : 259 - 264
[5] Prevention of respiratory syncytial virus (RSV) infection: RSV immune globulin intravenous and palivizumab
Canfield, SD
Simoes, EAF
PEDIATRIC ANNALS, 1999, 28 (08): : 507 - +
[6] Palivizumab: Preferred agent for prevention of RSV infection in high risk infants
不详
Drugs & Therapy Perspectives, 2000, 16 (2) : 1 - 5
[7] Palivizumab - the humanised monoclonal antibody for prevention of respiratory syncytial virus (RSV) infection
Scholz, H
ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE, 2000, 204 (03): : 120 - 122
[8] Respiratory syncytial virus (RSV) immune globulin and palivizumab for prevention of RSV infection (vol 57, pg 259, 2000)
Robinson, RF
Nahata, MC
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2000, 57 (07) : 699 - 699
[9] The RSV- Risk minimized! The Prevention with Palivizumab is from November 2015 more easier
Hoehl, Renate
Resch, Bernhard
PADIATRIE UND PADOLOGIE, 2015, 50 (05): : 218 - +
[10] Epidemiology of RSV and Non-RSV acute bronchiolitis and effectiveness of palivizumab
Tang, Chia-Wan
Hsieh, Kai-Shen
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 50 : S102 - S103

← 1 2 3 4 5 →